- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacovigilance in oncology
Authors
Keywords
Adverse drug reactions, Cancer, Cytotoxic chemotherapy, Neoplasms, Oncology, Pharmacovigilance, Radiotherapy, Safety, Targeted therapy, Toxicity
Journal
International Journal of Clinical Pharmacy
Volume 40, Issue 4, Pages 832-841
Publisher
Springer Nature America, Inc
Online
2018-08-01
DOI
10.1007/s11096-018-0706-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement
- (2018) Laura A. Levit et al. JOURNAL OF CLINICAL ONCOLOGY
- An historical overview over Pharmacovigilance
- (2018) Giulia Fornasier et al. International Journal of Clinical Pharmacy
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- Multidisciplinary Management of Breast Cancer During Pregnancy
- (2017) Shlomit Strulov Shachar et al. ONCOLOGIST
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs
- (2017) Ankur Arora et al. Therapeutics and Clinical Risk Management
- Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study
- (2017) Alison Pearce et al. PLoS One
- Radiodermatitis: A Review of Our Current Understanding
- (2016) Manni Singh et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
- (2016) F. Roila et al. ANNALS OF ONCOLOGY
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- The epidemiology of polypharmacy
- (2016) R. A. Payne CLINICAL MEDICINE
- Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
- (2016) Daphne Bertholee et al. CLINICAL PHARMACOKINETICS
- Immunotherapy to Treat Cancer
- (2016) JS McCune CLINICAL PHARMACOLOGY & THERAPEUTICS
- The US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) Program – Current Status and Future Direction
- (2016) Jasmanda Wu et al. CLINICAL THERAPEUTICS
- Digital Pharmacovigilance and Disease Surveillance: Combining Traditional and Big-Data Systems for Better Public Health
- (2016) Marcel Salathé JOURNAL OF INFECTIOUS DISEASES
- Pathology and biology of radiation-induced cardiac disease
- (2016) Soile Tapio JOURNAL OF RADIATION RESEARCH
- Generic oncology drugs: are they all safe?
- (2016) Y Tony Yang et al. LANCET ONCOLOGY
- Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up
- (2015) D. E. Peterson et al. ANNALS OF ONCOLOGY
- Approvals of drugs with uncertain benefit–risk profiles in Europe
- (2015) Rita Banzi et al. European Journal of Internal Medicine
- Utilizing social media data for pharmacovigilance: A review
- (2015) Abeed Sarker et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Toxicities and Adverse Drug Reactions Experienced During Anticancer Treatment: It Is Desirable to Consider the Problem Within the International System of Pharmacovigilance
- (2015) Paolo Baldo et al. JOURNAL OF CLINICAL ONCOLOGY
- Toxicities of Immunotherapy for the Practitioner
- (2015) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Forensic pharmacovigilance: Newer dimension of pharmacovigilance
- (2015) Rakesh K. Sewal et al. Journal of Forensic and Legal Medicine
- Current Practices in the Management of Adverse Events Associated With Targeted Therapies for Advanced Renal Cell Carcinoma: A National Survey of Oncologists
- (2014) Janelle Nicole Ruiz et al. Clinical Genitourinary Cancer
- Adverse reactions to oncologic drugs: spontaneous reporting and signal detection
- (2014) Marco Tuccori et al. Expert Review of Clinical Pharmacology
- Assessment of Risk Evaluation and Mitigation Strategies in Oncology: Summary of the Oncology Risk Evaluation and Mitigation Strategies Workshop
- (2013) James N. Frame et al. Journal of Oncology Practice
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Management of cancer pain: ESMO Clinical Practice Guidelines
- (2012) C. I. Ripamonti et al. ANNALS OF ONCOLOGY
- Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia–Romagna region)
- (2012) Chiara Biagi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The EU-ADR Web Platform: delivering advanced pharmacovigilance tools
- (2012) José Luis Oliveira et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials
- (2010) Bostjan Seruga et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now